[Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004977:Ethambutol; D012293:Rifampin
Retratamiento de tuberculosos resistentes a drogas de primera y segunda linea con rifamicina AMP y etambutol.